Vancomycin Derivatives with Siderophore Modification as Novel Antibiotics for Gram-Negative Bacteria

Research Triangle Institute, through inventors Chunyang Jin, Bruce Edward Blough, and Dongliang Guan, filed a patent application for novel vancomycin derivatives modified with siderophores to combat Gram-negative bacterial infections. The compounds target antimicrobial-resistant bacteria, specifically Acinetobacter baumannii and Escherichia coli. The application is classified under CPC codes C07K 9/008, A61P 31/04, and A61K 38/00.

Patent applicants and researchers in antibiotic development should note this filing as it represents a potential new approach to treating resistant Gram-negative infections. No immediate compliance actions or deadlines are associated with this patent application publication. Entities engaged in antimicrobial R&D may wish to conduct freedom-to-operate analyses if developing similar compounds.